Keyphrases
Core Outcome Set
100%
Randomized Controlled Trial
85%
Clinical Trials
32%
Urology
23%
Harms Reporting
20%
Type 1 Diabetes Mellitus (T1DM)
16%
Perioperative Pain
15%
Type I Diabetes
15%
Drug Companies
15%
Cost-plus
15%
Ketorolac
15%
Cuban
15%
Preterm Birth
14%
Medicare
12%
Data Extraction
10%
Clinical Trial Registry
10%
Medicare Part D
9%
Reporting Guidelines
8%
Inclusion Criteria
8%
Sectional Analysis
8%
Cost-savings Potential
7%
Preterm Birth Prevention
7%
Communication Disorders
7%
Macular Degeneration
7%
Most Cited Publications
7%
Stroke Trials
7%
Scientific Community
7%
Gender Representation
7%
Drosophila Species
7%
Top 100
7%
Mohs Micrographic Surgery
7%
Ethics Review Committees
7%
Bibliometric Analysis
7%
Parkinson's Disease
7%
Immune Thrombocytopenic Purpura
7%
Ovarian Cancer
7%
Lung Cancer
7%
Chronic Kidney Disease
7%
Inflammatory Bowel Disease
7%
Drosophilidae
7%
Diabetes Medications
7%
Seizure
7%
Patient-reported Outcomes
6%
NIH Funding
5%
Midwest
5%
Primary ITP
5%
Upward Trend
5%
Signaling Pathway
5%
Receptor Signaling
5%
Insulin-like
5%
Medicine and Dentistry
Randomized Controlled Trial
77%
Clinical Trial
46%
Systematic Review
25%
Cross Sectional Study
24%
Urology
23%
Ketorolac
15%
Symptom
13%
Mohs Surgery
7%
Insulin Dependent Diabetes Mellitus
7%
Lung Cancer
7%
Premature Labor
7%
Apoplexy
7%
Thrombocytopenic Purpura
7%
Ovarian Cancer
7%
Parkinson's Disease
7%
Inflammatory Bowel Disease
7%
Idiopathic Thrombocytopenic Purpura
7%
Chronic Kidney Disease
7%
Side Effect
5%
Quality of Life
5%
Patient-Reported Outcome
5%
Outcome Assessment
5%